Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-627-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 18 April 1984 to 2 February 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study was conducted by a GLP accredited laboratory using a method similar to OECD 475 Testing Guideline and meets acceptable scientific standards
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- Intraperitoneal injection not recommended as it is not a relevant route of human exposure. No historical data.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian germ cell cytogenetic assay
Test material
- Reference substance name:
- Distillates (petroleum), light catalytic cracked
- EC Number:
- 265-060-4
- EC Name:
- Distillates (petroleum), light catalytic cracked
- Cas Number:
- 64741-59-9
- IUPAC Name:
- 64741-59-9
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): Light catalytic cracked distillate (petroleum)
- Substance type: Hydrocarbons having carbon numbers predominantly in the range of C9 through C25. Also contains relatively large portion of bicyclic aromatic hydrocarbons
- Physical state: Light brown liquid
- Storage condition of test material: stored in the dark at room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratory
- Age at study initiation: 6-8 weeks
- Weight at study initiation: Male: 235-299g, Female: 150-204g
- Assigned to test groups randomly: yes
- Fasting period before study: no
- Housing: AAALAC-accredited facility
- Diet: ad libitum, certified laboratory rodent chow
- Water: ad libitum
- Acclimation period: 10-14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-27°C
- Humidity (%): 50±20%
- Photoperiod (hrs dark / hrs light): 12 hours dark, 12 hours light cycle
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Concentration of test material in vehicle: 0.3, 1.0 and 3.0 g/kg
- Lot/batch no. (if required): B11B - Duration of treatment / exposure:
- Immediate
- Frequency of treatment:
- Once
- Post exposure period:
- 6, 24, 48 hours
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
3.0g/kg
Basis:
no data
- Remarks:
- Doses / Concentrations:
1.0g/kg
Basis:
no data
- Remarks:
- Doses / Concentrations:
0.3g/kg
Basis:
no data
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- - Substance: triethylenemelamine
- Route of administration: IP
- Doses / concentrations: 0.5mg/kg
Examinations
- Tissues and cell types examined:
- Bone marrow cells
- Details of tissue and slide preparation:
- colchine injected into bone marrow at 1mg/kg to all rats two-four hours prior to sacrifice. After sacrifice bone marrow was aspirated into a syringe of HBSS (Hank's balanced salt solution) and stored till samples had been collected from all animals. They were then washed and mixed with Carnoy's fixative before being air dried on a slide the following day. The dry slides were stained with 4% Giemsa Stain and permanently mounted. Two slides were prepared per rat.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Remarks:
- no increase in number of cells with aberrations noted compared to vehicle control
- Toxicity:
- yes
- Remarks:
- Diarrhea, crusty eyes and noses observed in rats following a dose related correlation
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY
- Types of structural aberrations for significant dose levels: Gaps; chromosome and chromatid breaks; fragments; EX, DIC and RG rearrangements; Severe cell damage
- Appropriateness of dose levels and route: Intraperitoneal injection not recommended as it is not a relevant route of human exposure.
- Statistical evaluation: Student's t test, chi-square analysis
Any other information on results incl. tables
Chromosomal damage in bone marrow of rats after treatment with API 83-08
Substance | Concentration | Time (hr) | Total number of cells | Incidence of Aberrations (%) | Total number of aberrations | Aberrationsfrom severelydamaged cells | Aberrationsper cell | |||
Evaluated | With Aberrations | Gaps | Breaks | Rearrangments | ||||||
Corn Oil | 5ml/kg | 6 | 500 | 1 | 0.2 | 0 | 1 | 0 | 0 | 0.002 |
24 | 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
48 | 500 | 2 | 0.4 | 4 | 2 | 0 | 0 | 0.004 | ||
API 83-08 | 3.0mg/kg | 6 | 500 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
24 | 500 | 1 | 0.2 | 0 | 1 | 0 | 0 | 0.002 | ||
48 | 500 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | ||
1.0mg/kg | 6 | 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
24 | 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
48 | 500 | 1 | 0.2 | 5 | 1 | 0 | 0 | 0.002 | ||
0.3mg/kg | 6 | 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
24 | 500 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||
48 | 500 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | ||
TEM | 0.5mg/kg | 24 | 500 | 198 | 39.6 | 13 | 144 | 77 | 1250 | 2.942 |
Breaks include chromatid and chromosome breaks and fragments
Cells with more than 10 aberrations were counted as 10
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The test item was considered to be non-mutagenic under the conditions of the test. - Executive summary:
The in vivo cytogenicity of the test substance was determined according to a method similar to the OECD Guideline for Testing of chemicals 475. Chromosome aberrations were evaluated in Sprague-Dawley rats after administration by intraperitoneal route.
The results were negative for acute cytogenotoxicity. The animals were exposed to 0.2, 0.67, or 2g/kg of the test item using corn oil as a vehicle for 6, 24 and 48 hours before the rat was sacrificed and the bone marrow removed. The incidence of cells with aberrations was not significantly increased when compared to the vehicle control. Triethylenemelamine was used as a positive control. Rats showed signs of lethargic behaviour, scruffy coat, blood around nose, disorientation and uncoordination, and death on a dose and time related correlation.
The test item was therefore evaluated as none genotoxic under the conditions of this assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.